Results 1 to 10 of about 296,701 (305)

Factors affecting in-stent restenosis after angioplasty with the Enterprise stent for intracranial atherosclerotic diseases

Scientific Reports, 2021
This study investigated factors affecting the safety and in-stent restenosis after intracranial stent angioplasty using the Enterprise stent for symptomatic intracranial atherosclerotic stenosis.
Kun Zhang, Tian-Xiao Li, Zi-Liang Wang, Bu-Lang Gao, Jian-Jun Gu, Hui-Li Gao, Yong-Feng Wang, Jin-Chao Xia   +7 more
doaj   +2 more sources

In-Stent Restenosis and a Drug-Coated Balloon: Insights from a Clinical Therapeutic Strategy on Coronary Artery Diseases

Cardiology Research and Practice, 2020
Coronary heart disease is a major cause of death and disability in developed countries. Stent implantation has become an efficacious treatment for a culprit lesion vessel of the coronary artery.
Dai-Min Zhang, Shaoliang Chen
doaj   +2 more sources

In-stent restenosis

The Journal of Cardiovascular Surgery
Endovascular arterial recanalization has become the mainstay therapy for peripheral arterial occlusive disease. Although immediate technical success is achieved in greater than 90% of cases, longer-term results continue to vary based on the clinical presentation, and the treated target lesion.
El Khoury, Rym, Asha, Ahmad, Bystrom, Philip V, Weiss, Robert, Jacobs, Chad E, Schwartz, Lewis B   +5 more
semanticscholar   +7 more sources

Management of in-stent restenosis

EuroIntervention, 2022
In-stent restenosis (ISR) remains the most common cause of stent failure after percutaneous coronary intervention (PCI). Recent data suggest that ISR-PCI accounts for 5-10% of all PCI procedures performed in current clinical practice. This State-of-the-Art review will primarily focus on the management of ISR but will begin by briefly discussing ...
Alfonso, Fernando, Coughlan, J. Coughlan, Giacoppo, Daniele, Kastrati, Adnan, Byrne, Robert Byrne   +4 more
openaire   +5 more sources

In-Stent Restenosis [PDF]

JACC: Basic to Translational Science, 2020
Anna Lena Lahmann, MD, Michael Joner, MD
semanticscholar   +6 more sources

A computational model of coronary arteries with in-stent restenosis coupling hemodynamics and pharmacokinetics with growth mechanics [PDF]

Scientific Reports
Despite advances in stent technology, in-stent restenosis remains a critical challenge following percutaneous coronary intervention. In this work, we propose a comprehensive fluid-solid computational model to simulate restenosis after drug-eluting stent ...
Anna Ranno, Kiran Manjunatha, Thore Koritzius, Ivo Steinbrecher, Norbert Hosters, Maximilian Nachtsheim, Pakhwan Nilcham, Nicole Schaaps, Anne Turoni-Glitz, Janina Datz, Alexander Popp, Kevin Linka, Felix Vogt, Marek Behr   +13 more
doaj   +2 more sources

Effect of Epicardial Adipose Tissue on In-stent Restenosis after Percutaneous Coronary Intervention: a Review [PDF]

Zhongguo quanke yixue, 2023
As a major treatment for coronary artery disease, percutaneous coronary intervention (PCI) effectively enhances the survival rate of patients. However, the post-PCI in-stent restenosis has become a new cardiovascular problem that is difficult to solve ...
AN Jingjing, WANG Xiaojuan, DENG Aiyun
doaj   +1 more source

A predictive model involving serum uric acid, C-reactive protein, diabetes, hypercholesteremia, multiple lesions for restenosis risk in everolimus-eluting stent-treated coronary heart disease patients

Frontiers in Cardiovascular Medicine, 2022
PurposeAs a second-generation drug-eluting stent, the restenosis risk factors of the everolimus-eluting stent (EES) lack sufficient evidence. Therefore, the study investigated the in-stent restenosis occurrence and its predictive factors among patients ...
Qiang Feng, Ying Zhao, Haiyan Wang, Jiayu Zhao, Xun Wang, Jianping Shi   +5 more
doaj   +1 more source

In-stent restenosis after percutaneous coronary intervention: emerging knowledge on biological pathways

European Heart Journal Open, 2023
Percutaneous coronary intervention (PCI) has evolved significantly over the past four decades. Since its inception, in-stent restenosis (ISR)—the progressive reduction in vessel lumen diameter after PCI—has emerged as the main complication of the ...
F. Pelliccia, M. Zimarino, G. Niccoli, D. Morrone, G. De Luca, F. Miraldi, R. de Caterina   +6 more
semanticscholar   +1 more source

Intravascular Imaging for Guiding In‐Stent Restenosis and Stent Thrombosis Therapy

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2022
: Advances in stent technology and the design of endovascular devices with thinner struts, anti‐inflammatory and antithrombotic polymers, and better drug kinetics have enhanced the safety and efficacy of the second‐generation drug‐eluting stents and ...
E. Erdoğan, Retesh Bajaj, A. Lansky, A. Mathur, A. Baumbach, C. Bourantas   +5 more
semanticscholar   +1 more source